2-Oxo-Clopidogrel-d4

2-Oxo-Clopidogrel-d4 is a deuterated form of the antiplatelet drug, Clopidogrel. This drug is used to prevent blood clots in patients who have had a recent heart attack, stroke, or have peripheral arterial disease. 2-Oxo-Clopidogrel-d4 is a stable isotope-labeled compound that can be used as an internal standard for quantitative analysis of Clopidogrel in biological samples. The chemical structure of 2-Oxo-Clopidogrel-d4 is similar to that of Clopidogrel, with the addition of four deuterium atoms to the molecule. This labeling does not affect the pharmacological properties of the drug, but it does allow researchers to accurately measure the concentration of Clopidogrel in biological fluids using mass spectrometry. Clopidogrel works by inhibiting the activation of platelets, which are responsible for blood clotting. By preventing platelet activation, Clopidogrel reduces the risk of thrombosis, which can lead to heart attack or stroke. 2-Oxo-Clopidogrel-d4 is used in research studies to investigate the pharmacokinetics and pharmacodynamics of Clopidogrel, as well as to monitor drug therapy in patients. In conclusion, 2-Oxo-Clopidogrel-d4 is a useful tool for researchers studying the pharmacology of Clopidogrel. Its stable isotope labeling allows for accurate measurement of drug concentration in biological samples, which is important for optimizing drug therapy and understanding the mechanisms of action of Clopidogrel.